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Objective: To evaluate alcohol/tobacco/illicit drug use and sexual function in adolescent
juvenile idiopathic arthritis (JIA) and healthy controls.
Methods: 174 adolescents with pediatric rheumatic diseases were selected. A cross-
sectional study with 54 JIA patients and 35 controls included demographic/anthropometric
data  and puberty markers assessments, physician-conducted CRAFFT (car/relax/alone/
forget/friends/trouble) screen tool for substance abuse/dependence high risk and a ques-
tionnaire that evaluated sexual function, bullying and alcohol/tobacco/illicit drug use.
Clinical/laboratorial data and treatment were also assessed in JIA.
Results: The median current age was similar between JIA patients and controls [15(10–19)
vs.  15(12–18) years, p = 0.506]. Frequencies of alcohol/tobacco/illicit drug use were high and
similar in both JIA and controls (43% vs. 46%, p = 0.829). However, age at alcohol onset was
signiﬁcantly higher in those with JIA [15(11–18) vs. 14(7–18) years, p = 0.032], particularly in
polyarticular onset (p = 0.040). High risk for substance abuse/dependence (CRAFFT score ≥ 2)
was  found in both groups (13% vs. 15%, p = 1.000), likewise bullying (p = 0.088). Further analy-
sis  of JIA patients regarding alcohol/tobacco/illicit drug use showed that the median current
age  [17(14–19) vs. 13(10–19)years, p < 0.001] and education years [11(6–13) vs. 7(3–12)years,
p  < 0.001] were signiﬁcant higher in those that used substances. Sexual activity was signiﬁ-
cantly higher in the former group (48% vs. 7%, p < 0.001). A positive correlation was evidenced
between CRAFFT score and current age in JIA patients (p = 0.032, r = +0.296).
Conclusion: A high risk for substance abuse/dependence was observed in both JIA and con-
trols. JIA substance users were more likely to have sexual intercourse. Therefore, routinescreening is suggested in all visits of JIA adolescents.©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
∗ Corresponding author.
E-mail: clovisaasilva@gmail.com (C.A. Silva).
ttp://dx.doi.org/10.1016/j.rbre.2016.02.007
255-5021/© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/4.0/).
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Uso  de  substâncias  e  func¸ão sexual  na  artrite  idiopática  juvenil
Palavras-chave:
Álcool
Tabaco
Drogas ilícitas
Bullying
Artrite idiopática juvenil
r  e  s  u  m  o
Objetivo: Avaliar o uso de álcool/tabaco/drogas ilícitas e a func¸ão sexual em adolescentes
com artrite idiopática juvenil (AIJ) e controles saudáveis.
Métodos: Selecionaram-se 174 adolescentes com doenc¸as reumatológicas pediátricas. Fez-
se  um estudo transversal com 54 pacientes com AIJ e 35 controles. Foram feitas avaliac¸ões
de  dados demográﬁcos/antropométricos e marcadores da puberdade; a escala de triagem
CRAFFT (carro/relaxar/sozinho/esquecer/amigos/problemas) foi aplicada por um médico
para determinar o alto risco de uso abusivo/dependência de substâncias. Um questionário
avaliou a func¸ão sexual, a ocorrência de bullying e o uso de álcool/tabaco/drogas ilícitas.
Também foram avaliados dados clínicos/laboratoriais e de tratamento da AIJ.
Resultados: A idade média atual foi semelhante entre pacientes com AIJ e controles [15
(10  a 19) vs. 15 (12 a 18) anos, p = 0,506]. As frequências de uso de álcool/tabaco/drogas
ilícitas foram elevadas e semelhantes entre pacientes com AIJ e controles (43% vs. 46%,
p  = 0,829). No entanto, a idade em que comec¸ou a usar álcool foi signiﬁcativamente maior
naqueles com AIJ [15 (11 a 18) vs. 14 (7 a 18 anos), p = 0,032], em particular na doenc¸a de
início poliarticular (p = 0,040). Encontrou-se um alto risco de uso abusivo/dependência de
substâncias (pontuac¸ão no CRAFFT ≥ 2) em ambos os grupos (13% vs. 15%, p = 1,000), do
mesmo modo que o bullying (p = 0,088). Uma análise mais aprofundada dos pacientes com
AIJ  em relac¸ão ao uso de álcool/tabaco/drogas ilícitas mostrou que a idade média atual [17
(14  a 19) vs. 13 (10 a 19) anos, p < 0,001] e os anos de escolaridade [11 (6 a 13) vs. 7 (3 a 12) anos,
p  < 0,001] foram signiﬁcativamente maiores naqueles que usaram substâncias. A atividade
sexual foi signiﬁcativamente maior no primeiro grupo (48% vs. 7%, p < 0,001). Foi evidenciada
correlac¸ão  positiva entre a pontuac¸ão na escala CRAFFT e a idade atual dos pacientes com
AIJ (p = 0,032, r = +0,296).
Conclusão: Observou-se um alto risco de uso abusivo/dependência de substâncias em
pacientes com AIJ e controles. Os usuários de substâncias que têm AIJ são mais propen-
sos a ter relac¸ões sexuais. Portanto, sugere-se a triagem de rotina em todas as consultas de
adolescentes com AIJ.
© 2016 Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CCIntroduction
Adolescence is an important phase to develop a positive body
image, to establish social relationships, to achieve indepen-
dence and sexual identity. Some of the biggest problems
during this period in healthy adolescents are substance
misuse,1,2 precocious sexual activity, reduced use of con-
traceptive methods and higher risk of sexually transmitted
infections.3
In addition, the use of alcohol, tobacco and illicit drugs
seems to be relevant in adolescents with chronic conditions,
that may lead to addiction1 and high-risk sexual behavior.2,3
Smoking provoke cardiovascular disease and alcohol intake
can induce liver damage in patients with autoimmune dis-
eases under methotrexate therapy.3 The substance use in
chronic conditions may also induce poor adherence to medical
treatment, resulting in disease activity and decrease health-
related quality of life.
Adolescents may also suffer from bullying victimiza-
tion, particularly those with chronic diseases.4 However,
these issues have not been investigated simultaneously
in an adolescent juvenile idiopathic arthritis (JIA) popula-
tion.BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Therefore, the aims of the present study were to eval-
uate alcohol, tobacco and/or illicit drug use in adolescent
JIA patients and healthy controls. The possible associations
between the use of the aforementioned substances in JIA
patients and: demographic data, puberty markers, sexual
function, bullying, JIA clinical parameters and treatments
were also assessed.
Materials  and  methods
Patients  and  controls
We included all 174 adolescent outpatients (current age
10–19 years according to World Health Organization criteria)
with pediatric rheumatic diseases followed at the Pediatric
Rheumatology Unit of our University Hospital. These patients
were selected between February to June 2014. Out of them,
55 JIA adolescents were approached and recruited for this
study. The exclusion criterion was refusal to participate in
this study. Both patients and controls had no apparent psy-
chiatric disorders according the physician evaluation. One
patient was excluded due to autism. Therefore 54 adoles-
cents with JIA according to International League Against
 . 2 0 1
R
g
e
s
p
E
P
a
T
p
(
t
b
f
a
a
S
C
w
f
a
P
P
S
T
c
o
C
T
C
n
a
p
a
t
q
s
t
b
p
a
f
a
Q
A
a
T
q
tr e v b r a s r e u m a t o l
heumatism criteria5 were eligible to participate. The control
roup included 35 healthy adolescents, without chronic dis-
ases, referred from the primary and secondary health care
ervices to the Adolescent Unit of our teaching University Hos-
ital. This cross-sectional study was approved by the Local
thics Committee of our University Hospital.
uberty  markers,  sexual  function  and
lcohol/tobacco/illicit  drug  use,  and  bullying
his study included demographic/anthropometric data and
uberty markers assessments. The Portuguese CRAFFT
mnemonic acronym of car, relax, alone, forget, friends and
rouble) screen (CRAFFT/CEASER) version was performed for
oth groups.2,6 A modiﬁed questionnaire evaluated sexual
unction,7 alcohol/tobacco/illicit drug use and bullying. These
spects were carried out blinded to JIA clinical, laboratorial
nd treatment data conducted by a single investigator.
ocio-demographic  and  anthropometric  data
urrent age, gender, years of education, weight and height
ere evaluated. Body mass index (BMI) was deﬁned by the
ormula: weight in kilograms/height in square meters.
The Brazilian socio-economic classes were classiﬁed
ccording to the ABEP (Associac¸a˜o Brasileira de Empresas de
esquisa).8
uberty  markers  assessments
econdary sexual characteristics were classiﬁed according to
anner pubertal changes.7 Age at ﬁrst menstruation (menar-
he) and ﬁrst ejaculation (spermarche) were registered based
n memory  recollection.
RAFFT  screening
he validated Portuguese version of physician-conducted
RAFFT (CRAFFT/CEASER) screen was used and consisted of
ine questions developed to screen adolescents for high-risk
lcohol and drug use.6 This questionnaire is divided in two
arts. Part A includes three questions regarding the use of
lcohol, marijuana, hashish or another substance in the last
welve months. If the adolescent responded “no” to all three
uestions, only the question related to “car” of the B-part
hould be asked. If the adolescent answered “yes” to one of
he opening questions, all of the questions of part B should
e asked. B-part contained six questions, which are signs of
roblematic substance use. One point was given to each “yes”
nswer in the B-part of the questionnaire. The score ranged
rom 0 to 6. A total score of ≥2 indicated high risk for substance
buse/dependence and a need for additional assessment.2,6
uestionnaire  administration
 pilot study was carried out in 30 consecutive healthy and JIA
dolescents, who  were tested and retested after 1–2 months.
he pretest evaluated the subjects’ comprehension of the
uestions, the consistency and coherence of the answers and
he time taken to answer the questionnaire. The questionnaire 6;5 6(4):323–329 325
included 14 questions with the option of answer “yes/no”
or age/number of times about sexual function, bullying and
alcohol/tobacco/illicit drugs use. Sexual function assessment
included: age at ﬁrst sexual intercourse, sexual intercourse in
the last month, use of male contraceptive (condom) in the
ﬁrst sexual activity, current use of oral and emergency con-
traceptive, knowledge of sexual activity by parents and total
number of sexual partners. Alcohol/tobacco and drugs [illicit
inhalants drug (glue snifﬁng, aerosol and solvents) and illicit
drugs [marijuana, stimulants (cocaine, crack and speed), pop-
pers, LSD, opiates, heroin, crystal meth and ecstasy] use were
also assessed: age at alcohol initiation, number of days of alco-
hol used in the last 30 days, age at smoking initiation, number
of days using cigarettes in the last 30 days, age at illicit drug
initiation and number of days using illicit drugs in the last
30 days. Bullying, which is deﬁned as a recurrent exposure
to emotional and/or physical aggression, was obtained by a
“yes/no” answer to the question “Have you ever suffered bul-
lying?”. The questionnaire was strictly conﬁdential and was
performed in the absence of legal guardians, relatives and
friends.
JIA  clinical,  laboratorial  and  treatment  assessments
Clinical assessments of JIA patients were assessed at the
study entry and included: number of active joints (swelling
within a joint, or limitation in the range of joint move-
ment with joint pain or tenderness), number of limited
joints, patient and physician global assessment of arthritis
activity measured in a 10 cm horizontal visual analog scale
(VAS), morning stiffness duration and Brazilian version of
Childhood Health Assessment Questionnaire (CHAQ).9 Labo-
ratorial assessment included erythrocyte sedimentation rate
(ESR > 20 mm/1st hour) (Westergren method) and C-reactive
protein (CRP > 5 mg/L) (nephelometry). Data concerning the
use and current dosage of non-steroidal anti-inﬂammatory
drugs (NSAIDs), prednisone, DMARDs (methotrexate, sul-
phasalazine and leﬂunomide), immunosuppressive drugs
(cyclosporine) and biological agents (adalimumab, etanercept,
tocilizumab and abatacept) were also determined.
Statistical  analysis
The test–retest reliability of the modiﬁed questionnaire was
veriﬁed using the Kappa index. Results were presented as the
mean ± standard deviation (SD) or median (range) for con-
tinuous and number (%) for categorical variables. Data were
compared by t or Mann–Whitney tests in continuous vari-
ables to evaluate differences between JIA and controls, and
between JIA subgroups. For categorical variables, differences
were assessed by Fisher’s exact or Pearson chi-square tests.
Spearman rank correlation coefﬁcient was used for correla-
tions between CRAFFT score and age. The level of signiﬁcance
was set at 5% (p < 0.05).Results
The kappa index for test–retest was 0.850, demonstrating
excellent reliability for the adolescents’ responses.
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Table 1 – Demographic data, puberty markers, sexual function, alcohol, tobacco and illicit drug use, and bullying in
adolescents with juvenile idiopathic arthritis (JIA) and controls.
Variables JIA
(n = 54)
Healthy controls
(n  = 35)
p
Demographic data
Current age, yrs 15 (10–19) 15 (12–18) 0.506
Female gender 38 (70) 26 (74) 0.688
BMI, kg/m2 20.79 (13.2–35.6) 19.53 (16.4–25.9) 0.205
Social economic class B and C 51 (94) 34 (97) 1.000
Education, yrs 9 (3–13) 10 (6–12) 0.826
Puberty markers
Tanner 3 7 (13) 4 (11) 1.000
Tanner 4 10 (19) 12 (34) 0.102
Tanner 5 30 (57) 19 (54) 0.830
Menarche 32/38 (84) 26/26 (100) 0.073
Menarche age, yrs 12 (9–15) 11.5 (9–15) 0.528
Spermarche 10/16 (63) 7/9 (78) 0.661
Spermarche age, yrs 13 (10–15) 13 (12–14) 0.959
Sexual function
Sexual activity 13  (24) 9 (26) 0.861
First sexual activity age, yrs 15 (13–17) 15 (12–17) 0.606
Sexual intercourse in last month 8/13 (62) 4/9 (44) 0.666
Condom at the ﬁrst sexual activity 13/13 (100) 8/9 (89) 0.409
Oral contraception use in females 5/11 (46) 3/10a (30) 0.659
Emergency contraceptive use 4/11 (36) 4/9 (44) 1.000
Knowledge of sexual activity by parents 9/13 (69) 6/8 (75) 1.000
Total number of sexual partner, number 2.5 (1–5) 1 (1–2) 0.071
Alcohol, tobacco and/or illicit drug use 23  (43) 16 (46) 0.829
Alcohol use 23 (43) 16 (46) 0.829
Age at onset alcohol, yrs 15 (11–18) 14 (7–18) 0.032
Polyarticular onset JIA, n = 17 15 (13–17) 14 (7–18) 0.040
Systemic onset JIA, n = 19 15 (11–17) 14 (7–18) 0.188
Drinking alcohol in past 30 days, number 0 (0–7) 0 (0–5) 0.505
Tobacco use 4 (7) 5 (14) 0.308
Age at onset smoking, yrs 16 (13–18) 15 (7–15) 0.250
Smoking in past 30 days, number 0 0 (0–30) 0.180
Illicit drug use 1 (2) 2 (6) 0.559
Age at onset illicit drug, yrs 14 14 1.000
Illicit drug use in past 30 days, number 0 (0–0) 1.5 (0–3) 0.480
CRAFFT score (0–6) 0 (0–3) 0 (0–5) 0.836
CRAFFT score ≥ 2 7 (13) 5 (15) 1.000
CRAFFT item
Car 14/54 (26) 5/34 (15) 0.213
Relax 4/16 (25) 2/11 (18) 1.000
Alone 1/16 (6) 1/11 (9) 1.000
Forget 2/16 (13) 5/11 (46) 0.084
Friends 5/16 (31) 5/11 (46) 0.687
Trouble 1/16 (6) 0 (0) 1.000
Bullying 11/43 (26) 15/34 (44) 0.088
CRAFFT, car, relax, alone, forget, friends, trouble in the last 12 months; screening test.
y.The results are presented in n (%) and median (range) or mean ± SD.
a One healthy control used oral contraception before sexual activit
The median current age was similar between JIA patients
and controls [15 (10–19) vs. 15 (12–18) years, p = 0.506], likewise
the frequency of female gender (p = 0.688), years of educa-
tion (p = 0.826), social economic classes (p = 1.000) and Tanner
5 (p = 0.830). The median menarche age and spermarche age
were also alike [12 (9–15) vs. 11.5 (9–15) years, p = 0.528 and
13 (10–15) vs. 13 (12–14) years, p = 0.959], respectively, as well
as frequency of sexual activity (p = 0.861) and age of the ﬁrstsexual intercourse [15 (13–17) vs. 15 (12–17) years, p = 0.606]
(Table 1).
The frequencies of alcohol, tobacco and/or illicit drug use
were high and similar in both JIA patients and controls (43% vs.
46%, p = 0.829). However, the age at alcohol onset was signiﬁ-
cantly higher in those with JIA compared to healthy controls
[15 (11–18) vs. 14 (7–18) years, p = 0.032], especially in polyartic-
ular JIA onset (n = 17) [15 (13–17) vs. 14 (7–18) years, p = 0.04].
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Table 2 – Demographic data, puberty markers, bullying and disease parameters in adolescents with juvenile idiopathic
arthritis (JIA) according to alcohol, tobacco and illicit drug use.
Variables Use alcohol, tobacco and/or
illicit drug
(n = 23)
Non use alcohol, tobacco and/or
illicit drug
(n = 31)
p
Demographic data
Current age, yrs 17 (14–19) 13 (10–19) <0.001
Disease duration, yrs 6 (1–17) 4 (0.25–15) 0.063
Female gender 16 (70) 22 (71) 0.911
BMI, kg/m2 21.15 (18–27) 20.09 (13–30) 0.132
Social economic class B and C 22 (96) 28 (90) 0.628
Education, yrs 11 (6–13) 7 (3–12) <0.001
Puberty markers
Tanner 3 1 (4) 6 (20) 0.123
Tanner 4 3 (13) 7 (23) 0.484
Tanner 5 19 (83) 11 (37) 0.001
Menarche 16 (100) 16 (73) 0.030
Menarche age, yrs 12 (9–15) 12 (9–14) 0.861
Spermarche 7 (100) 3 (33) 0.011
Spermarche age, yrs 13 (12–15) 11 (10–13) 0.082
Sexual function
Sexual activity 11  (48) 2 (7) <0.001
First sexual activity age, yrs 16 (13–17) 14 (14) 0.227
Sexual intercourse in last month 7/11 (64) 1/2 (50) 1.000
Condom at the ﬁrst sexual activity 11/11 (100) 2/2 (100) 1.000
Oral contraception use in females 4/9 (44) 1/2 (50) 1.000
Emergency contraceptive use 4/9 (44) 0 0.491
Knowledge of sexual activity by parents 7/11 (64) 2/2 (100) 1.000
Total number of sexual partner, number 3 (1–5) 1 (1) 0.074
Bullying 5/18 (28) 6/25 (24) 1.000
JIA parameters
Morning stiffness 7 (30) 2/29 (7) 0.061
Morning stiffness, min 30 (10–120) 20 (10–30) 0.492
Active joints 7 (30) 10 (32) 0.887
Number of active joints 1 (1–8) 1 (1–9) 0.956
Limited joints 16 (70) 20 (65) 0.697
Number of limited joints 2 (1–11) 3.5 (1–61) 0.165
ESR, mm/1st h 14.5 (2–60) 20 (2–47) 0.809
ESR, >20 mm/1st h 10/22 (46) 11/27 (41) 0.740
CRP, mg/L 2.23  (0–76) 1.23 (0–155) 0.847
CRP, >5 mg/L 6/22 (27) 7/26 (27) 0.978
Patient’s VAS, cm 1 (0–9) 1 (0–5) 0.748
Physician’s VAS, cm 0 (0–4) 1 (0–4) 0.307
CHAQ 0.56 (0–2.6) 0.63 (0–1.5) 0.779
Current treatment 19 (83) 29 (94) 0.384
NSAID 7 (30) 16 (52) 0.120
Naproxen 2 (9) 6 (19) 0.443
Glucocorticoids 3 (13) 8 (26) 0.319
Dose, mg/day 11.3 (2.5–40) 5 (2.5–25) 0.214
Methotrexate 4 (17) 6 (19) 1.000
Dose, mg/week 25 (10–50) 25 (10–37.5) 0.731
Leﬂunomide 3 (13) 5 (16) 1.000
Dose, mg/day 20 (20) 20 (10–20) 0.094
Sulfasalazine 0 1 (3) 1.000
Cyclosporine 2 (9) 3 (10) 1.000
Dose, mg/day 190 (180–200) 150 (100–200) 0.584
Biological agents 12 (52) 10 (32) 0.141
Abatacept 1 (4) 2 (7) 1.000
Etanercept 5 (22) 3 (10) 0.217
Adalimumab 4 (17) 3 (10) 0.443
Tocilizumab 2 (9) 2 (7) 1.000
The results are presented in n (%) and median (range) or mean ± SD, CRAFFT (car, relax, alone, forget, friends, trouble) screening test.
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Illicit drugs were used by one JIA patient (marijuana and
cocaine) and two controls (marijuana) (p = 0.559) and no dif-
ference was observed in the frequency of tobacco use. CRAFFT
score ≥ 2 was similar in both groups (13% vs. 15%, p = 1.000). Of
our 7 JIA patients with CRAFFT score ≥ 2, 4 had polyarticular
onset, 5 used methotrexate and 6 biological agents. The fre-
quency of bullying was lower in patients with JIA vs. controls,
however it did not reach statistical signiﬁcance (26% vs. 44%,
p = 0.088) (Table 1).
Of JIA subtypes, systemic onset was observed in 19 patients,
polyarticular in 17, pauciarticular in 13, enthesitis-related
arthritis in 3 and psoriatic arthritis in 2. Further analysis of
JIA patients regarding alcohol/tobacco/illicit drug use showed
that the median current age [17 (14–19) vs. 13 (10–19) years,
p < 0.001] and education years [11 (6–13) vs. 7 (3–12) years,
p < 0.001] were signiﬁcantly higher in those that used the afore-
mentioned substances. The frequencies of Tanner 5 (p = 0.001),
menarche (p = 0.030) and spermarche (p = 0.011) were also sig-
niﬁcantly higher in the former group, likewise sexual activity
(48% vs. 7%, p < 0.001). No differences were evidenced between
alcohol/tobacco/illicit drug use and disease parameters and
current treatment in both groups (p > 0.05, Table 2).
A positive correlation was evidenced between CRAFFT
score and current age in JIA patients (p = 0.032, r = +0.296),
with no correlation in controls (p = 0.571). No correlations were
evidenced between CRAFFT score and age of alcohol onset
(p = 0.751), onset of sexual intercourse (p = 0.606) and education
years (p = 0.066) in JIA patients.
Discussion
To the best of our knowledge, this was the ﬁrst study that
assessed simultaneously adolescent health issues in JIA pop-
ulation and controls, and evidenced a higher age at alcohol
onset in patients, mainly in polyarticular subtype. In the JIA
adolescent group, substance users were more  likely to have
sexual intercourse. We  also found a higher risk for substance
abuse/dependence at later age in JIA adolescents.
The advantage of the present study was the evaluation of
physician-conducted CRAFFT (CEASER) screening tool. This
score is used to determine the high-risk of alcohol and drug
dependence in adolescents.2,6 A questionnaire with excellent
test–retest reliability that evaluated sexual function, bullying
and licit/illicit drug consumption was also used. A healthy
control group with similar age, academic background, gender
and socio-economic class was pertinent herein, since these
data were related with bullying and drug use.1,2 However, the
main weaknesses of this study was the cross sectional anal-
ysis, as well as the small sample studied and the lack of the
evaluation of different forms of bullying.
Alcohol use was previously reported in 36% of adolescent
and young adults with pediatric rheumatic diseases.10 In addi-
tion, Nash et al. reported a 19% of alcohol experimentation
in 52 JIA adolescents,11 contrasting to 43% observed herein.
This ﬁnding may be related to an increased alcohol intake in
adolescents during the nineties12 and the economic growth
in our country,13 thus enabling middle socio-economic class
to consume. Therefore, restriction strategies are required to
decrease alcohol use. 0 1 6;5 6(4):323–329
Of note, the age at alcohol onset was higher in JIA patients,
especially in polyarticular onset under methotrexate and bio-
logical agents. Our patients ignored the information to avoid
substance use concomitant to biological and non-biological
DMARDs, with a high risk to adverse events, particularly
hepatotoxicity.11 We  used a screening procedure for substance
use.2,6 Indeed, CRAFFT score ≥ 2 in our JIA patients indicated
higher risk for substance abuse/dependence.2 Based on that,
additional assessment and therapeutic intervention with a
multidisciplinary and multiprofessional team is required.
Importantly, JIA substance users engaged more  in sex-
ual activity, with possible unsafe sexual relations, sexually
transmitted diseases and pregnancy. This ﬁnding may be also
related to the fact that the patients were older with higher
sexual maturity. Despite JIA is a painful, chronic and disability
disease, and may inﬂuence sexual function,14,15 our patients
presented their ﬁrst sexual activity earlier.
A delay of puberty markers was not evidenced in JIA
patients, which is a distinct pattern in our adolescent
with juvenile systemic lupus erythematosus15 and juve-
nile dermatomyositis.16 In addition, bullying was frequently
reported in JIA and controls that may cause depression, anx-
iety and interfere with proper adherence of medication use.4
A prospective study, recruiting larger sample of JIA and evalu-
ating these aspects, will be necessary.
In conclusion, high risk for substance abuse/dependence
was observed in both JIA and controls. JIA substance users
were more  likely to have sexual intercourse. Our study rein-
forces that JIA adolescents should be systematically screened
by pediatricians for sexual, alcohol and drugs health behav-
ioral patterns, as part of Pediatric Rheumatology service visits.
Alcohol and contraception education to JIA patients, especially
those treated with methotrexate and biologic agents, should
be included in the routine care.
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